It is the most abundant adipokine in the serum [10], and multiple studies have linked low levels of adiponectin with increased risk of endothelial dysfunction, hypertension, obesity and insulin resistance [11] Conversely, a protective role of adiponectin has been implicated in cardiovascular and bronchial inflammatory states [12–17]. This evidence concerns the gene ADIPOQ and endothelial dysfunction.